Skip to main content

Table 2 Analyses of risk factors for the incidence of liver failure in the TB-HBV group (n = 58)

From: Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

Factors Univariate analysis Multivariate analysis
OR 95%CI P-value OR 95%CI P-value
Age > 50 1.306 0.43, 3.95 0.636 1.024 0.26, 3.99 0.973
Male 3.469 0.53, 22.80 0.195 1.199 0.14, 10.09 0.868
Alcohol intake > 40 g/d 0.429 0.06, 1.57 0.272
INH + RFP 0.533 0.15, 1.93 0.339 0.586 0.13, 2.61 0.483
Latency < 1 month 0.429 0.09, 1.94 0.272
Hepatocellular DILI 0.638 0.19, 2.15 0.467
Cirrhosis 9.545 7.7, 170.83 0.001 9.648 2.39, 38.87 0.001
HBV DNA > 20,000 IU/ml 1.045 0.34, 3.18 0.938 0.607 0.16, 2.33 0.466
  1. Abbreviations: TB tuberculosis, INH isoniazid, RFP rifampin, DILI drug-induced liver injury, HBV hepatitis B virus